Related Experiment Video
Updated: Sep 25, 2025

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
FOXA1 transcription activates TFF1 to reduce 6-OHDA-induced dopaminergic neuron damage
Tingting Liang1, Ping Zhao1, Xiao Zhang1
1Department of Neurology, The Affiliated Lianyungang Oriental Hospital of Xuzhou Medical University, Lianyungang, Jiangsu 222042, P.R. China.
Abstract:
Forkhead box A1 (FOXA1) plays an important role in the central nervous system, and its loss can lead to the downregulation of tyrosine hydroxylase, which directly affects the synthesis of dopamine, thus leading to Parkinson's disease (PD). The present study aimed to explore the specific role of FOXA1 in PD. Blood samples from patients with PD were collected to determine the expression levels of FOXA1 using reverse transcription-quantitative PCR (RT-qPCR). In addition, mouse dopaminergic neuron MES23.5 cells were induced with 6-hydroxydopamine (6-OHDA) to construct an in vitro PD model in order to study the effect of FOXA1 overexpression on cell inflammation, oxidative stress and apoptosis with RT-qPCR, assay kits and TUNEL assays, respectively. Subsequently, the expression of FOXA1 was silenced to assess the effect on the downstream mechanism. The results revealed that the expression level of FOXA1 was downregulated in patients with PD, and FOXA1 overexpression attenuated 6-OHDA-induced inflammation, oxidative stress and apoptosis in MES23.5 cells. Furthermore, FOXA1 could bind to the trefoil factor 1 (TFF1) promoter, and the effects of FOXA1 overexpression on cells were reversed by TFF1 silencing, indicating that TFF1 mediated the mechanism of FOXA1 overexpression in MES23.5 cells. In conclusion, following FOXA1 transcription, TFF1 expression was activated, thereby relieving 6-OHDA-induced cell inflammation, oxidative stress and apoptosis. The present findings suggested that FOXA1 may serve as a target for the treatment of PD.
Insights
Forkhead box A1 (FOXA1) is downregulated in Parkinson's disease (PD). Overexpressing FOXA1 reduces inflammation, oxidative stress, and apoptosis in PD models by activating trefoil factor 1 (TFF1).
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Forkhead box A1 (FOXA1) is crucial in the central nervous system and linked to dopamine synthesis.
- Downregulation of FOXA1 affects tyrosine hydroxylase, impacting dopamine synthesis and potentially leading to Parkinson's disease (PD).
Purpose of the Study:
- To investigate the specific role of FOXA1 in Parkinson's disease (PD).
- To explore the therapeutic potential of FOXA1 in PD treatment.
Main Methods:
- Examined FOXA1 expression in PD patients' blood via RT-qPCR.
- Utilized a 6-hydroxydopamine (6-OHDA) induced in vitro PD model using MES23.5 cells.
- Assessed FOXA1 overexpression effects on inflammation, oxidative stress, and apoptosis using RT-qPCR, assay kits, and TUNEL assays.
- Investigated FOXA1's downstream mechanism, including binding to the trefoil factor 1 (TFF1) promoter and effects of TFF1 silencing.
Main Results:
- FOXA1 expression was significantly downregulated in patients with PD.
- Overexpression of FOXA1 attenuated 6-OHDA-induced inflammation, oxidative stress, and apoptosis in MES23.5 cells.
- FOXA1 directly binds to the TFF1 promoter, and TFF1 silencing reversed the protective effects of FOXA1 overexpression.
- FOXA1 activates TFF1 transcription, which in turn alleviates 6-OHDA-induced cellular damage.
Conclusions:
- FOXA1 plays a protective role in PD by reducing inflammation, oxidative stress, and apoptosis.
- The mechanism involves FOXA1-mediated transcriptional activation of TFF1.
- FOXA1 represents a potential therapeutic target for Parkinson's disease.
More Related Videos
08:37Fluorescence Activated Cell Sorting FACS and Gene Expression Analysis of Fos-expressing Neurons from Fresh and Frozen Rat Brain Tissue
Published on: August 27, 2016
09:54Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
General Transcription Factors
Master Transcription Regulators
TGF - β Signaling Pathway